Photo of Jennifer R. Bellon,  MD

Jennifer R. Bellon, MD

Dana-Farber Cancer Institute

Dana-Farber Cancer Institute
Phone: (617) 632-3591

Jennifer R. Bellon, MD

Dana-Farber Cancer Institute

EDUCATIONAL TITLES

  • Associate Professor, Radiation Oncology, Harvard Medical School
  • Director, Breast Radiation Oncology, Radiation Oncology, Dana-Farber Cancer Institute

DF/HCC PROGRAM AFFILIATION

Publications

Powered by Harvard Catalyst
  • Bellon JR, Chen YH, Rees R, Taghian AG, Wong JS, Punglia RS, Shiloh RY, Warren LEG, Krishnan MS, Phillips J, Pretz J, Jimenez R, Macausland S, Pashtan I, Andrews C, Isakoff SJ, Winer EP, Tolaney SM. A Phase 1 Dose-Escalation Trial of Radiation Therapy and Concurrent Cisplatin for Stage II and III Triple-Negative Breast Cancer. Int J Radiat Oncol Biol Phys 2021. PubMed
  • McDuff SGR, Bellon JR, Shannon KM, Gadd MA, Dunn S, Rosenstein BS, Ho AY. ATM Variants in Breast Cancer: Implications for Breast Radiotherapy Treatment Recommendations. Int J Radiat Oncol Biol Phys 2021. PubMed
  • Tabrizi S, Trippa L, Cagney D, Aizer AA, Tanguturi S, Ventz S, Fell G, Bellon JR, Mamon H, Nguyen PL, D'Amico AV, Haas-Kogan D, Alexander BM, Rahman R. Assessment of Simulated SARS-CoV-2 Infection and Mortality Risk Associated With Radiation Therapy Among Patients in 8 Randomized Clinical Trials. JAMA Netw Open 2021; 4:e213304. PubMed
  • Mittendorf EA, Bellon JR, King TA. Regional Nodal Management in Patients With Clinically Node-Negative Breast Cancer Undergoing Upfront Surgery. J Clin Oncol 2020. PubMed
  • Bradley JA, Bellon JR. Quality of Life and Limb: Reducing Lymphedema Risk After Breast Cancer Therapy. Int J Radiat Oncol Biol Phys 2020; 106:225-229. PubMed
  • Braunstein LZ, Bellon JR. Contemporary Issues in Breast Cancer Radiotherapy. Hematol Oncol Clin North Am 2020; 34:1-12. PubMed
  • Wright JL, Bellon JR. Defining the Optimal Schedule for External Beam Partial Breast Irradiation. Int J Radiat Oncol Biol Phys 2019; 104:867-868. PubMed
  • Jagsi R, Griffith KA, Bellon JR, Woodward WA, Horton JK, Ho A, Feng FY, Speers C, Overmoyer B, Sabel M, Schott AF, Pierce L, . Concurrent Veliparib With Chest Wall and Nodal Radiotherapy in Patients With Inflammatory or Locoregionally Recurrent Breast Cancer: The TBCRC 024 Phase I Multicenter Study. J Clin Oncol 2019; 36:1317-1322. PubMed
  • Bellon JR, Guo H, Barry WT, et al. Local-regional recurrence in women with small node-negative, HER2 positive breast cancer: results from a prospective multi-institutional study (the APT trial) Breast Cancer Res Treat 2019.